Risk factors
Z Squared (ZSQR) risk factors
Item 1A of every Z Squared Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors34 risks1 reworded
Risk section changes are minimal, featuring only a reworded disclosure on Nasdaq listing requirements for risk 31.
Filed Mar 19, 2026 - FY2024 10-K risk factors34 risks
Z Squared faces substantial going concern doubt with minimal cash, negative cash flows, and no bank credit lines. Development heavily depends on clinical trials, regulatory approvals, and third-party intellectual property licenses. The company relies on key personnel like CEO David Mehalick and lacks independent market studies for its business plan.
Filed Mar 28, 2025